We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

The company will be the first to integrate whole genome sequencing (WGS) into Epic's Aura platform, further advancing access ...

The study will screen babies for more than 200 genetic conditions to enable earlier diagnosis.

We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ:TEM) stands against other ...

has announced the development of a whole-genome sequencing test, named xH, aimed at enhancing personalized treatment for hematological cancer patients. According to InvestingPro data, the company ...

CHICAGO - Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence applications for precision medicine with a market capitalization of $5.9 billion and impressive revenue growth of 32% ...

Mohbad's widow, Omowunmi has accused her late husband's father, Joseph Aloba, of avoiding a DNA test to resolve the dispute ...

It was mutually decided not to go ahead with whole genome sequencing ... Hospital and NIV-Pune have been designated to conduct HMPV testing. "Our focus is on elderly and paediatric patients.